Cadila Healthcare to acquire Windlass Healthcare

Sanket Dewarkar
/ Categories: Trending, Markets

Drug manufacturer Cadila Healthcare plans to acquire 51 per cent stake in Windlass Healthcare for Rs 155.55 crore, the company informed on Tuesday.

Through this acquisition, the company aims to expand its pharma manufacturing footprint, said the company's filing to the exchange. The cost of acquisition is Rs. 155.55 crore and the deal will be completed by the end of September 2018

Cadila Healthcare has entered into an agreement to acquire 51 per cent share capital of Windlass Healthcare Private Limited (WHPL). Windlass Healthcare has reported sales of Rs. 33.31 crore for fiscal 2018. Windlass Healthcare has a robust manufacturing infrastructure with USFDA inspected oral solids manufacturing facility.

On Tuesday, the stock has opened at Rs.35.90 per share and touched high/low of 360.40/336.25 and closed at Rs.339.80, down by 4.17 per cent

Previous Article Thirumalai Chemicals surges 13 per cent on ex-date
Next Article Bhageria Industries receives clearance for sulphuric acid plant
Rate this article:
5.0

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR